Ligand Pharma (LGND) Tops Q4 EPS by 43c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
February 17, 2022 4:01 PM ESTConference Call Begins at 4:30 p.m. Eastern Time Today
EMERYVILLE, Calif.--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2021, and provided an operating forecast and business updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.
2021 was an outstanding year for Ligand, both operationally and financially. The execution by the team and the performance of the business throughout the past several months... More
